Skip to content

Use of guided imagery in patients with fibromyalgia: effects on pain, self agency and physical functioning

Use of guided imagery in patients with fibromyalgia: effects on pain, self agency and physical functioning - Use of guided imagery in patients with fibromyalgia

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33658
Enrollment
60
Registered
2009-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fibromyalgia fibromyalgia syndrome

Interventions

The experimental condition consists of group support (2 meetings) guided by a specialised rheumatology nurse in combination with instruction about and use of guided imagery techniques. Participants

Sponsors

NIVEL
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - suffering from fibromyalgia for less than 3 years - being able to come to the 2 group meetings in Utrecht - being able to participate in 2 group meetings of about 1,5 hour each - no severe hearing disabilities - speaking Dutch

Exclusion criteria

Exclusion criteria: - already using guided imagery techniques - having a comorbid psychiatric disorder

Design outcomes

Primary

MeasureTime frame
Primary outcomes of the study are pain, self efficacy and functional status. The measurement instruments to assess these outcomes are largely overlapping with the instruments used in the afore mentioned studies of Fors et al. (2002) and Menzies et al. (2006). To assess pain a Visual Analogue Scale will be used, on which patients have to rate their pain at a scale from 0 to 10. This pain-VAS has to be rated daily in a pain diary during 4 subsequent weeks (between group meeting 1 and 2) and at the three measurement moments. In addition, for assessing pain the McGill Pain Questionnaire (dutch version-MPQ-DLV). This is a broadly-used, valid and reliable pain instrument consisting of 17 items on the nature of the pain complaints. For measuring self efficacy at the three measurement points the Dutch version of the Arthritis Self-Efficacy Scale (ASES) will be used. This scale has three subscales: (1) self-efficacy regarding pain management, (2) self-efficacy regarding other symptoms, (3) self-efficacy regarding functioning. This instrument will be adapted in the sense that the word arthritis will be replaced by fibromyalgia. To assess the functional status the Dutch version of the Fibromyalgia Impact Scale will be used, consisting of 19 items about physical functioning in the last week.

Secondary

MeasureTime frame
----

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)